首页> 美国卫生研究院文献>BMC Cancer >A molecular and staging model predicts survival in patients with resected non-small cell lung cancer

【2h】

A molecular and staging model predicts survival in patients with resected non-small cell lung cancer

机译：分子和分期模型预测切除的非小细胞肺癌患者的生存

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundThe current TNM staging system is far from perfect in predicting the survival of individual non-small cell lung cancer (NSCLC) patients. In this study, we aim to combine clinical variables and molecular biomarkers to develop a prognostic model for patients with NSCLC.

机译：背景技术当前的TNM分期系统在预测单个非小细胞肺癌（NSCLC）患者的存活率方面还不够完善。在这项研究中，我们旨在结合临床变量和分子生物标记物，开发出NSCLC患者的预后模型。

著录项

期刊名称 BMC Cancer
作者
Lei Liu; Minxin Shi; Zhiwei Wang; Haimin Lu; Chang Li; Yu Tao; Xiaoyan Chen; Jun Zhao;
展开▼
作者单位

展开▼
年(卷),期 2018(18),-1
年度 2018
页码 966
总页数 8
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词
Non-small cell lung cancer Survival TPX2 MMP12;

机译：非小细胞肺癌;生存;TPX2;MMP12;
入库时间 2022-08-21 11:06:38

相似文献

外文文献
中文文献
专利

1. A molecular and staging model predicts survival in patients with resected non-small cell lung cancer [J] . Lei Liu, Minxin Shi, Zhiwei Wang, BMC Cancer . 2018,第1期

机译：分子和分期模型预测切除的非小细胞肺癌患者的存活
2. Fluorine-18 fluorodeoxyglucose positron emission tomographic maximal standardized uptake value predicts survival independent of clinical but not pathologic TNM staging of resected non-small cell lung cancer. [J] . Downey RJ, Akhurst T, Gonen M, The Journal of Thoracic and Cardiovascular Surgery . 2007,第6期

机译：氟-18氟脱氧葡萄糖正电子发射断层显像的最大标准化摄取值可预测生存，与切除的非小细胞肺癌的临床但非病理性TNM分期无关。
3. Fluorine-18 fluorodeoxyglucose positron emission tomographic maximal standardized uptake value predicts survival independent of clinical but not pathologic TNM staging of resected non-small cell lung cancer [J] . Robert J. Downey, Timothy Akhurst, Mithat Gonen, The journal of thoracic and cardiovascular surgery . 2007,第6期

机译：氟-18氟脱氧葡萄糖正电子发射断层扫描的最大标准化摄取值可预测切除的非小细胞肺癌的临床生存期，而与病理TNM分期无关
4. Gene expression profiles predict survival of patients with advanced non-small cell lung cancers [C] . Harun Roslan, Hadi Jalal, Mhazir Nur Shukriyah, 2011 Fourth International Conference on Modeling, Simulation and Applied Optimization . 2011

机译：基因表达谱预测晚期非小细胞肺癌患者的生存
5. The cost effectiveness of screening for early stage lung cancer and the testing and treatment of molecular subgroups among non-small cell lung cancer patients in the province of ontario, canada [D] . Thao, Mallory. 2014

机译：加拿大安大略省非小细胞肺癌患者早期肺癌筛查的成本效益及分子亚群的检测和治疗
6. The direct and indirect impact of comorbidity on the survival of patients with non-small cell lung cancer: a combination of survival staging and resection models with missing measurements in covariates [O] . Maria Iachina, Anders Green, Erik Jakobsen 2014

机译：合并症对非小细胞肺癌患者生存的直接和间接影响：生存分期和切除模型的组合以及协变量测量值的缺失
7. Elevated pretreatment neutrophil/white blood cell ratio and monocyte/lymphocyte ratio predict poor survival in patients with curatively resected non-small cell lung cancer: Results from a large cohort [O] . Cheng Yuan, Ning Li, Xiaoyong Mao, 2017

机译：升高的预处理中性粒细胞/白细胞比和单核细胞/淋巴细胞比率预测患有患病性非小细胞肺癌患者的患者存活率差：大队列的结果

A molecular and staging model predicts survival in patients with resected non-small cell lung cancer

摘要

著录项

相似文献

相关主题

期刊订阅